Answers are grounded in this paper and cite their sources.
Inflammation score may be associated with OS in adrenergic tumors of patients >18 months with stage IV disease. A, OS was significantly better for TCI tumors than NI tumors in ADRN patients in this subgroup of the Discovery cohort and B, trended similarly in the Validation cohort. C, There was no difference in survival for patients with MES tumors according to TCI status in this subgroup in the Discovery cohort. D, The MES patients in this subgroup in the Validation cohort also had no difference in OS according to the TCI status.
No takes yet. Share an insight, caveat, or question.
Kaufman et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: